ストックスクリーナーアプリを入手
1.05
5.52%
0.0549
前日終値:
$0.9951
開ける：
$1
24時間の取引高:
677.56K
Relative Volume:
0.21
時価総額：
$23.61M
収益：
$2.05M
当期純損益:
$-23.15M
株価収益率:
-0.1583
EPS:
-6.6319
ネットキャッシュフロー:
$-16.93M
1週間 パフォーマンス:
-9.48%
1か月 パフォーマンス:
-5.41%
6か月 パフォーマンス:
+36.29%
1年 パフォーマンス:
-57.14%
1日の値動き範囲:
$0.961
$1.07
1週間の範囲:
$0.961
$1.277
52週間の値動き範囲:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
IBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.05 | 22.38M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 開始されました | Oppenheimer | Outperform |
| 2025-10-17 | 開始されました | Leerink Partners | Outperform |
| 2024-05-28 | 開始されました | Chardan Capital Markets | Buy |
| 2021-11-29 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-01-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 開始されました | Alliance Global Partners | Buy |
すべてを表示
iBio Inc (IBIO) 最新ニュース
iBio Confirms Directors and Auditor at Annual Meeting - TipRanks
iBio shareholders elect directors and approve annual meeting proposals - Investing.com
How robust is iBio Inc. (0JV0) stock financial position2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Can trapped investors hope for a rebound in iBio Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
iBio, Inc. (IBIO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How iBio Inc. (0JV0) stock responds to job market shiftsJobs Report & Momentum Based Trading Signals - newser.com
Is iBio Inc. stock safe for conservative investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
Why hedge funds are buying iBio Inc. stockJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Will iBio Inc. stock deliver better than expected guidanceMarket Volume Summary & Stock Portfolio Risk Management - newser.com
Why iBio Inc. (0JV0) stock trades below fair valueWeekly Risk Report & Verified Entry Point Signals - newser.com
Is iBio Inc. (0JV0) stock supported by free cash flowJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock is rated strong buyTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Why analysts raise outlook for iBio Inc. (0JV0) stock2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock appeals to dividend seekersJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Is iBio Inc. (0JV0) stock a fit for income portfoliosEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Why iBio Inc. (0JV0) stock could be next leaderPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Is iBio Inc. (0JV0) stock a top dividend aristocrat candidate - newser.com
Using AI based signals to follow iBio Inc.2025 Pullback Review & Risk Managed Trade Strategies - newser.com
What high frequency data says about iBio Inc.Quarterly Risk Review & Technical Entry and Exit Tips - newser.com
iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Certain Warrants of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Prefunded Warrants of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Restricted Stock Units of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Options of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
[8-K] iBio, Inc. Reports Material Event | IBIO SEC FilingForm 8-K - Stock Titan
iBio, Inc. Reports Q3 2025 Financial Results - MSN
iBio Inc (IBIO) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):